Pine Valley Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Pine Valley Investments's GILD Position: Q2 2026 in Review
Pine Valley Investments increased its Gilead Sciences (GILD) stake by 7.5% in Q2 2026, buying an estimated $24.1K and bringing the position to 2,610 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #479.
Pine Valley Investments first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $338K in Q1 2026. 1,239 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Pine Valley Investments held 2,610 shares of Gilead Sciences worth $330K as of Q2 2026.
- Pine Valley Investments bought 183 Gilead Sciences shares in Q2 2026, an estimated $24.1K.
- Gilead Sciences made up 0.01% of Pine Valley Investments's portfolio in Q2 2026, its #479 holding.
- Pine Valley Investments first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
- Pine Valley Investments's Gilead Sciences position peaked at $338K in Q1 2026.
- 1,239 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.